In continuation of the Intimation filed by us on 30th November, 2024 and in pursuant to Regulation 30 of read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, (Listing regulations), Welcure Drugs & Pharmaceuticals has informed that the Board of Directors at their meeting held today i.e., December 02, 2024 have transacted the following businesses: Conduct Postal Ballot by means of E-voting for obtaining approval of the members on the resolutions as mentioned in the Notice of Postal Ballot to be sent to the shareholders of the Company for approval following items: To Approve the appointment of Pradeep Dnyaneshwar Terse (DIN 10758084) as Non-Executive Independent Director; Appointment of Vishakha Agrawal of Vishakha Agrawal& Associates, Practicing Company Secretaries, as the Scrutinizer to scrutinize the Postal Ballot by the means of e-voting in a fair and transparent manner; The Board considered and approved Cut-Off date i.e. Friday, November 29, 2024 for the purpose of member eligible for sending notice of postal ballot and for voting. The meeting of the Board commenced at 12:00 PM (IST) and concluded at 12:30 PM (IST).
The above information is a part of company’s filings submitted to BSE.